Susan was Chief Technology Officer at 2Seventy Bio, and Senior Vice President, Oncology Technical Development and Operations at Genetix Biotherapeutics. Susan Abu-Absi joined Be Biopharma in 2025.
Susan Abu-Absi is currently
Create your alert
to follow the career of Susan Abu-Absi.
Do you need to know more about Susan Abu-Absi? More results.
Report an error
Update the org chart details of Susan Abu-Absi.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.